Argent BioPharma (ASX:RGT) suspends trading for major update

 Argent BioPharma  has announced that its securities will be placed in a trading halt effective immediately.

The company made the request to the Australian Securities Exchange (ASX) pending the release of an important announcement. 

The anticipated announcement is related to a capital raising effort.

The trading halt will remain in place until the earlier of the commencement of normal trading on Tuesday, 2 July 2024, or when the company makes its announcement public.